Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q1 2022 · 10-Q
Revenue$60.00K$60.00K+30.4% vs Q1 2021 Net Income-$3.33M-$3.33MN/M vs Q1 2021 EPS, diluted—
Operating Income-$3,327,000N/M Operating Cash Flow-$2,913,000N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Free Cash Flowderived-$2,942,000N/M Margins · derivedOperating margin-5545.0%+915.9 pt vs Q1 2021
Net margin-5541.7%+912.7 pt vs Q1 2021
ended Mar 31, 2022 · filed May 11, 2022 · 41 d after period end